RTW Investments’s Tango Therapeutics TNGX Stock Holding History

RTW Investments’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$435M	Buy	13,900,620 +600,000	+5%	+$14.8M	3.71%	7
2026 Q1	$278M	Buy	13,300,620 +11,809,392	+792%	+$164M	2.77%	8
2025 Q4	$13.2M	Buy	+1,491,228	New	+$12.8M	0.13%	67
2024 Q1	–	Sell	-1,966,752	Closed	-$19.5M	–	77
2023 Q4	$19.5M	Buy	+1,966,752	New	+$17.1M	0.3%	43
2022 Q1	–	Sell	-180,819	Closed	-$1.98M	–	120
2021 Q4	$1.98M	Sell	180,819 -419,181	-70%	-$5.04M	0.03%	109
2021 Q3	$7.76M	Hold	600,000	–	–	0.12%	82
2021 Q2	$6.83M	Hold	600,000	–	–	0.1%	82
2021 Q1	$6.67M	Hold	600,000	–	–	0.1%	83
2020 Q4	$6.86M	Hold	600,000	–	–	0.12%	77
2020 Q3	$6.22M	Buy	+600,000	New	+$6.13M	0.15%	75

Other funds holding TNGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RTW Investments's TNGX Position: Q2 2026 in Review

RTW Investments increased its Tango Therapeutics (TNGX) stake by 4.5% in Q2 2026, buying an estimated $14.8M and bringing the position to 13,900,620 shares worth $435M. The position accounts for 3.71% of the portfolio, ranked #7.

RTW Investments first reported a position in TNGX in Q3 2020 and has held it in 10 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

RTW Investments held 13,900,620 shares of Tango Therapeutics worth $435M as of Q2 2026.
RTW Investments bought 600,000 Tango Therapeutics shares in Q2 2026, an estimated $14.8M.
Tango Therapeutics made up 3.71% of RTW Investments's portfolio in Q2 2026, its #7 holding.
RTW Investments first reported a position in Tango Therapeutics in Q3 2020 and has held it in 10 quarters since.
248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on RTW Investments's 13F filing for Q2 2026, filed 14 Aug 2026.